Visceral adipose tissue is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.
Updated 2026-01-08. Numbers and descriptions here follow the published literature rather than marketing material.
Tesamorelin is a synthetic peptide that acts as an analog of growth hormone-releasing hormone, a natural hypothalamic signal. Its sequence corresponds to the forty-four amino acid form of the human hormone, with a small acyl group attached near the amino terminus. That modification slows enzymatic breakdown and extends the time the peptide remains active in circulation. The compound was developed as a pharmacological way to raise endogenous growth hormone output rather than supplying the hormone directly.
After injection, the peptide binds receptors on somatotroph cells in the anterior pituitary. Receptor activation raises intracellular cyclic AMP and triggers release of stored growth hormone into the bloodstream. Because the compound works through the body's own regulatory system, growth hormone pulses retain much of their normal feedback control. Repeated administration also raises insulin-like growth factor 1, a hormone produced mainly in the liver. Investigators treat that rise as a marker that the pituitary axis has been engaged.
作用位置在垂体前叶。tesamorelin 与 GHRH 受体结合后激活腺苷酸环化酶，升高细胞内 cAMP，再经蛋白激酶 A 通路促进生长激素的合成与释放。由于它作用于内源调控节点，生长激素仍以脉冲方式分泌，而不是被持续抬升到固定水平。生长激素随后在肝脏等组织诱导胰岛素样生长因子 1 产生，构成完整的生长激素轴响应。
研究背景集中在特定人群的体成分改变，尤其是与脂肪分布异常相关的内脏脂肪堆积。不同地区对它的监管状态与获批适应症并不一致，部分市场仅限特定诊断人群使用。在一般人群中的长期效应、与其他激素的相互作用以及停药后的维持情况仍属开放问题，现有数据不足以给出普遍结论。
| Property | Value | Notes |
|---|---|---|
| Drug class | Peptide hormone analog | Acts at the growth hormone-releasing hormone receptor |
| Receptor | Growth hormone-releasing hormone receptor | G protein-coupled; raises cyclic AMP in somatotrophs |
| Key mediator | Insulin-like growth factor 1 | Increases with repeated administration |
| Main studied population | Adults with HIV-associated lipodystrophy | Trials measured visceral adipose tissue by imaging |
| Route | Subcutaneous injection | Given once daily in clinical use |
A Phase 3 program led to regulatory approval in the United States in 2010 for reduction of excess visceral abdominal fat in adults with HIV and lipodystrophy. Subsequent studies examined effects on liver fat, muscle area, and metabolic markers, with mixed findings for some endpoints. Long-term cardiovascular outcomes and effects on mortality remain uncertain because most trials were relatively short and focused on imaging-based fat measurements. Use in populations without HIV has been studied experimentally but is not part of the approved indication.
Tesamorelin is a synthetic analog of growth hormone-releasing hormone, a peptide hormone produced by the hypothalamus. The molecule retains the 44-amino-acid sequence of human GHRH and carries a trans-3-hexenoyl modification at its N-terminus. This modification increases resistance to enzymatic degradation and extends the peptide's functional stability relative to native GHRH. The compound is supplied as a lyophilized powder for reconstitution and subcutaneous administration in clinical settings. Its development code was TH9507, and it belongs to the GHRH analog class. It is not a growth hormone product; instead, it acts upstream to stimulate endogenous growth hormone release.
Clinical interest in tesamorelin arose from the need to address visceral adiposity in people living with HIV. Antiretroviral therapy improved survival but was associated in some patients with central fat accumulation, altered lipid profiles, and metabolic complications. This condition, often called HIV-associated lipodystrophy, involves excess visceral adipose tissue that is difficult to manage through diet and exercise alone. Investigators evaluated tesamorelin because GHRH analogs can stimulate growth hormone secretion and influence fat distribution without direct liposuction or invasive procedures.
=== Julia Braverman-Graham === Julia Braverman-Graham (Erika Christensen) is Sydney and Victor's mother, Joel's wife, and Zeek and Camille's fourth and youngest child and second daughter. She is a lawyer at a top corporate firm while her husband, Joel, supports her ambitions by serving as a stay-at-home dad to their daughter. Julia is sometimes competitive and it is difficult for her to let go and relax. Julia's go-getting personality and by-the-book approach is the opposite of her sister Sarah's, but they turn to one another for support. During the second season, Joel and Julia are celebrating their eight-year anniversary. After unsuccessfully trying to conceive a second child, Julia is told she has scarring in her uterus and that it will be extremely difficult for her to conceive again. Julia and Joel decide to adopt a young boy named Victor. During the fourth season, after missing Sydney's dance recital and Victor's first baseball game, as well as a discovery deadline for the law firm (a costly mistake for the firm), she quits her job at the firm. She then attempts to become a stay-at-home mom while Joel goes back to work. In season five, Julia begins to struggle with staying at home and feeling out of place. She begins a friendship with Ed, a dad at her children's school, and it begins to turn into an emotional affair. Eventually she sees the dangers and goes to break it off, but instead they kiss. Later in the season, after separating with Joel over her relationship with Ed, Julia has a one-night stand with Mr.
Sheila Sue Moriber Katz (February 1, 1943 – September 10, 2023) was an American pathologist and writer, dean of the Hahnemann University School of Medicine, and co-founder of the School of Public Health at Drexel. She is sometimes described as the first person to see the bacterium Legionella pneumophila, which causes Legionnaires' disease.
==== Organic molecules ==== A recent international project has developed and determined the hydrogen, carbon, and nitrogen isotopic composition of 19 organic isotopic reference materials, now available from USGS, IAEA, and Indiana University. These reference materials span a large range of δ2H (-210.8‰ to +397.0‰), δ13C (-40.81‰ to +0.49‰), and δ15N (-5.21‰ to +61.53‰), and are amenable to a wide range of analytical techniques. The organic reference materials include caffeine, glycine, n-hexadecane, icosanoic acid methyl ester (C20 FAME), L-valine, methylheptadecanoate, polyethylene foil, polyethylene power, vacuum oil, and NBS-22.
=== Kimchi === Kimchi (김치) is the accepted word in both North and South Korean standard languages. Earlier forms of the word include thimchoy (팀ᄎᆡ), a Middle Korean transcription of the Sino-Korean word 沈菜 (literally "submerged vegetable"). Thimchoy appears in Sohak Eonhae, the 16th-century Korean rendition of the Chinese book, Xiaoxue. Sound changes from Middle Korean to Modern Korean regarding the word can be described as:
Sources: en.wikipedia.org
The 2008 Chinese milk scandal was a significant food safety incident in China. The scandal involved Sanlu Group's milk and infant formula along with other food materials and components being adulterated with the chemical melamine, which resulted in kidney stones and other kidney damage in infants. The chemical was used to increase the nitrogen content of diluted milk, giving it the appearance of higher protein content in order to pass quality control testing. 300,000 affected children were identified, among which 54,000 were hospitalized, according to the latest report in January 2009. The deaths of six babies were officially concluded to be related to the contaminated milk. The timeline of the scandal dated back to December 2007, when Sanlu began to receive complaints about kidney stones. An early complaint was made on 20 May 2008, when a mother posted online after she learnt that Sanlu had donated the milk she had been complaining about to the orphans of the 2008 Sichuan earthquake. Also on 20 May, the problem was raised at Sanlu's Board meeting for the first time and they ordered multiple third-party tests. The culprit, melamine, was undetected in the tests until 1 August.
Within the immune system, prolactin acts to promote lymphocyte differentiation, proliferation, and function through the activation of protein kinase C signaling pathway. Prolactin has immunomodulatory and anti-inflammatory effects within the immune system, contributing to immune system maintenance. Stress also acutely stimulates prolactin production, as dopamine (a prolactin inhibitor) levels are reduced under stress, the pituitary gland is in turn expressed more leading to higher prolactin levels.
Upon arriving on the island in April 1565, the Spanish colonizers called the land Negros, after the dark-skinned natives they had observed. Two of the earliest native settlements, Binalbagan and Ilog, became towns in 1573 and 1584, respectively, while other settlements of the period included Hinigaran, Bago, Marayo (now Pontevedra), Mamalan (now Himamaylan), and Candaguit (now a sitio of San Enrique). After appointing encomenderos for the island, Miguel López de Legazpi placed Negros under the jurisdiction of the governor of Oton in Panay. In 1734, however, the island became a military district with Ilog as its first capital. The seat of government was later transferred to Himamaylan until Bacolod became the capital in 1849. In 1865, Negros and its outlying minor islands along with Siquijor was converted into a politico-military province. By the end of the 1700s, Negros Island had 5,741 native families. By 1818, Negros Island had 200 Spanish-Filipino and Spanish-Filipino Mestizo tributes-families. Of which, Dumaguete had 25 Spanish-Filipino families; Amlan had 155 Spanish-Filipino families; Ilog had 25 Spanish-Filipino families; Bacolod had 37 Spanish-Filipino families; and finally, Silay had 25 Spanish-Filipino families. In 1890, the island was officially partitioned into the present-day provinces of Negros Occidental and Negros Oriental. The Spanish Governor, D. Isidro Castro y Cinceros, surrendered to the Negros Revolutionaries, led by Aniceto Lacson and Juan Araneta, on November 6, 1898. General Miller appointed Aniceto as Governor of the Island in March 1899.
It was estimated in 2017 that nearly one in three persons globally had at least one form of malnutrition: wasting, stunting, vitamin or mineral deficiency, overweight, obesity, or diet-related noncommunicable diseases. Undernutrition is more common in developing countries. Stunting is more prevalent in urban slums than in rural areas. Studies on malnutrition have the population categorised into different groups including infants, under-five children, children, adolescents, pregnant women, adults and the elderly population. The use of different growth references in different studies leads to variances in the undernutrition prevalence reported in different studies. Some of the growth references used in studies include the National Center for Health Statistics (NCHS) growth charts, WHO reference 2007, Centers for Disease Control and Prevention (CDC) growth charts, National Health and Nutrition Examination Survey (NHANES), WHO reference 1995, Obesity Task Force (IOTF) criteria and Indian Academy of Pediatrics (IAP) growth charts. In 2023, an estimated 28.9 percent of the global population – 2.33 billion people – were moderately or severely food insecure.
Authentic extracts elevated to the rank of originals (Series A); Declarations by individuals (Series B); Official reconstructions based on documents held by the administration or registers transferred to it (Series C). This operation lasted until 1897 and ended due to a lack of funds. It made it possible to restore slightly more than 2.6 million records, most of which date from the 19th century. Only 347,000 records were restored for the Ancien Régime, with just five dating back to the 16th century. Altogether, the restored documents represent only one-third of those that were destroyed. Birth records are the most numerous, with approximately 1,422,000 records dating from 1550 to 1859, compared to around 922,000 death records from 1568 to 1859 and 322,000 marriage records from 1630 to 1859. However, the vast majority of data, particularly that concerning families without descendants, is lost forever. The reconstructed records are preserved at the Archives of Paris. Their duplicates, stored at the Montlignon Fort (Val-d’Oise), were destroyed in a fire in June 1974.
Sources: en.wikipedia.org
=== Further clinical studies === Ga-NODAGA-JR11 had entered further clinical studies as an imaging agent, while and Lu-DOTA-JR11 had similar research done as a therapeutic agent, as JR11 has a high binding affinity for ssrt2 subtype receptors which are highly expressed on the surface of tumor cells. Gallium-containing agonists had already been established as an imaging agent. Lutetium-containing agonists were used as a therapeutic agent in peptide receptor radionuclide therapy, due to the lower energy electrons emitted, and γ-emission causing easier dose adjustment to patient characteristics to avoid renal damage. The NODAGA chelator was used over DOTA in Gallium antagonists due to higher binding affinity, while no Lu-NODAGA compounds were developed due to established usage of Lu-DOTA derivative agonist drugs, and poor uptake compared to DOTA, which is reverse that of the gallium-containing antagonists.
North-West Europe 1944–45 Tobruk 1941 Benghazi Raid North Africa 1940–43 Landing in Sicily Sicily 1943 Termoli Valli di Comacchio Italy 1943–45 Greece 1944–45 Adriatic Middle East 1943–44 Falkland Islands 1982 Western Iraq Gulf 1991
Cysteine (; symbol Cys or C) is a semiessential proteinogenic amino acid with the formula HS−CH2−CH(NH2)−COOH. The thiol side chain in cysteine enables the formation of disulfide bonds, and often participates in enzymatic reactions as a nucleophile. Cysteine is chiral, but both D- and L-cysteine are found in nature. L‑Cysteine is a protein monomer in all biota, and D-cysteine acts as a signaling molecule in mammalian nervous systems. Cysteine is named after its discovery in urine, which comes from the urinary bladder or cyst, from Greek κύστις kýstis, "bladder". The thiol is susceptible to oxidation to give the disulfide derivative cystine, which serves an important structural role in many proteins. In this case, the symbol Cyx is sometimes used. The deprotonated form can generally be described by the symbol Cym as well. When used as a food additive, cysteine has the E number E920. Cysteine is encoded by the codons UGU and UGC.
Gastric pentadecapeptide BPC-157 (also known as Body Protection Compound 157, bepecin, or PL 14736) is a synthetic fifteen amino acid oligopeptide derived from a protein found in human gastric juice. BPC-157 has been studied primarily in laboratory animals. BPC-157 is not approved by any drug regulatory agency for human use, and there is limited data regarding its effectiveness on humans. The peptide has gained popularity among athletes and the general public for injury recovery, leading the World Anti-Doping Agency to ban it in 2022. Health authorities discourage its use due to insufficient human safety data, and some jurisdictions have restricted it as a prescription-only medicine despite it not being available through legitimate prescriptions. Additionally, because the compound promotes blood vessel formation (angiogenesis), there are theoretical concerns about potential cancer promotion that require further investigation. The peptide was discovered during research on human gastric juice. The amino acid sequence is Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val. BPC-157 is stable at room temperature and bioavailable in rodent models when administered IM or IV. The peptide demonstrates unusual stability in human gastric juice, remaining intact for more than 24 hours.
Histatins are encoded by two genes, HTN1 and HTN3. The primary members include histatin 1 (38 amino acids), histatin 3 (32 amino acids), and histatin 5 (24 amino acids), with histatin 5 derived from proteolytic cleavage of histatin 3. Histatin 1 (UniProt ID: P15515) is notable for its phosphorylation at serine residues, which enhances its binding to hydroxyapatite in the acquired enamel pellicle.
Sources: en.wikipedia.org
It is a laboratory-made peptide that mimics growth hormone-releasing hormone. It prompts the pituitary gland to release growth hormone and has been studied mainly in adults with HIV-associated lipodystrophy.
Administered growth hormone supplies the hormone directly, while this peptide acts upstream by prompting the pituitary to release it. The indirect route preserves pulsatile secretion and some endogenous feedback, which changes the hormone and IGF-1 profile observed after treatment.
Reductions in visceral adipose tissue appear consistently in randomized trials of the approved population. Effects on peripheral fat, cardiovascular outcomes, and use outside that population are less well established.
tesamorelin 属 GHRH 类似物，作用于垂体受体以促进内源生长激素释放；生长激素本身是直接补充的外源激素。两者在给药逻辑、作用位点和反馈调控路径上并不相同。